ProCertus BioPharm, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1997-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.procertus.com
Clinical Trials
3
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (100.0%)Exploratory Study of Topical Norepinephrine in Breast Cancer Patients Receiving Radiotherapy
- First Posted Date
- 2012-03-06
- Last Posted Date
- 2012-05-28
- Lead Sponsor
- ProCertus BioPharm, Inc
- Registration Number
- NCT01544504
- Locations
- 🇺🇸
H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
Exploratory Study of Norepinephrine to Prevent Alopecia in Head and Neck Cancer Patients Treated With Radiotherapy
- First Posted Date
- 2011-06-07
- Last Posted Date
- 2012-03-23
- Lead Sponsor
- ProCertus BioPharm, Inc
- Target Recruit Count
- 3
- Registration Number
- NCT01367990
- Locations
- 🇺🇸
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
Exploratory Study of Norepinephrine to Prevent Radiodermatitis in Breast Cancer Patients
- First Posted Date
- 2010-12-20
- Last Posted Date
- 2013-04-19
- Lead Sponsor
- ProCertus BioPharm, Inc
- Target Recruit Count
- 10
- Registration Number
- NCT01263366
- Locations
- 🇺🇸
University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, United States
News
No news found